Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anshul Shah
Clinical and Economic Outcomes of Treatment Sequences for Intermediate- To Poor-Risk Advanced Renal Cell Carcinoma
Immunotherapy
Oncology
Allergy
Immunology
Related publications
Real-World Clinical Outcomes of Pazopanib Immediately Following Immunotherapy Discontinuation for the Treatment of Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Puk9 - Network Meta-Analysis of Treatments in Previously Untreated Advanced or Metastatic Renal-Cell Carcinoma With Intermediate to Poor Prognosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nivolumab in the Treatment of Advanced Renal Cell Carcinoma
Oncology in Clinical Practice
Oncology
Economic Evaluation of Nivolumab as a Second-Line Treatment for Advanced Renal Cell Carcinoma From US and Chinese Perspectives
Cancer
Cancer Research
Oncology
Molecular Marker for Predicting Treatment Response in Advanced Renal Cell Carcinoma: Does the Promise Fulfill Clinical Need?
Current Urology Reports
Medicine
Urology
Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Cabozantinib in Combination With Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Molecular Cancer Therapeutics
Cancer Research
Oncology
M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging